Go Pro
NASDAQ:BXBL

BOXABL (BXBL) Stock Price, News & Analysis

BOXABL logo
$6.02 -1.99 (-24.88%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About BOXABL Stock (NASDAQ:BXBL)

Advanced

Key Stats

Today's Range
$6.00
$8.29
50-Day Range
N/A
52-Week Range
$6.00
$15.14
Volume
743,477 shs
Average Volume
143,583 shs
Market Capitalization
$15.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BXBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BOXABL and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BXBL Stock News Headlines

Boxabl logo hangs above a factory floor where workers assemble modular building units on a production line.
Boxabl Disrupts Housing With A Tiny Float IPO
Boxabl debuted via SPAC at a $3.5 billion valuation with a tiny 1.38 million-share float, as legacy builders D.R. Horton and Lennar face margin pressure and rising inventory.
NNVC: FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles — a disease with no approved antiviral treatment currently on the market. NV-387 is designed as a broad-spectrum antiviral with potential applications across RSV, influenza, coronaviruses, Mpox, and more. With Phase II trials advancing and measles cases resurging globally, NNVC is entering a notable inflection point.tc pixel
See More Headlines

BXBL Stock Analysis - Frequently Asked Questions

BOXABL's stock was trading at $9.82 on July 20, 2026. Since then, BXBL stock has decreased by 35.6% and is now trading at $6.3250.

Shares of BXBL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Residential Construction
Sub-Industry
N/A
Current Symbol
NASDAQ:BXBL
Previous Symbol
NASDAQ: FGMC
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.43 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
597.61%
Return on Assets
1.69%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.88
Quick Ratio
0.88

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.34 per share
Price / Cash Flow
17.86
Book Value
$0.15 per share
Price / Book
40.84

Miscellaneous

Outstanding Shares
2,600,000
Free Float
N/A
Market Cap
$15.93 million
Optionable
N/A
Beta
0.10
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:BXBL) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners